John McDonough, President & CEO at T2 Biosystems, Inc. (TTOO), sold 8,134 shares at $3.36 ($27K) on 2019-02-11, disclosed to the SEC on 2019-02-12.
Scheduled sale ($27k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TTOO | SELL | 2020-01-27 | $132K | — | Filing → |
| TTOO | SELL | 2019-02-05 | $49K | — | Filing → |
| TTOO | SELL | 2018-06-08 | $27K | — | Filing → |